Xiaofeng Li

Chronic inflammation‐elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance

Xiaofeng Li, Cheng Chen, Daimin Xiang et al. · Hepatology · 2017 · 123 citations · Full text

Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors

Zhonghua Pei, Xiaofeng Li, Kenton L. Longenecker et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +14

Disposition and Drug-Drug Interaction Potential of Veliparib (ABT-888), a Novel and Potent Inhibitor of Poly(ADP-ribose) Polymerase

Xiaofeng Li, Juergen Delzer, Richard Voorman et al. · Drug Metabolism and Disposition · 2011 · 60 citations

Discovery of ((4<i>R</i>,5<i>S</i>)-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8<i>H</i>)-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Zhonghua Pei, Xiaofeng Li, Thomas W von Geldern et al. · Journal of Medicinal Chemistry · 2006 · 52 citations · Full text

Orally Efficacious, Pharmacotherapy, Pharmaceutical Chemistry +18

Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas

Yu Zhang, Jia Luo, Zhe Liu et al. · Bioscience Reports · 2021 · 50 citations · Full text